Neurovascular Devices Market Key Companies and SWOT Analysis by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPAR100000781
  • Category : Life Sciences
  • No. of Pages : 234
  • Available Report Formats : pdf-format excel-format
Buy Now
Neurovascular Devices Market Key Companies and SWOT Analysis by 2027
Report Date: Oct 2020   |   Report Code: TIPAR100000781 Email: sales@theinsightpartners.com
Buy Now

The Neurovascular Devices Market was valued at US$ 2,997.36 million in 2019 and is projected to reach US$ 3,871.20 million by 2027; it is expected to grow at a CAGR of 3.2% from 2020 to 2027. 

Neurovascular devices are used in neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.

The scope of the Neurovascular Devices market includes product, application, end user, and region. The market for Neurovascular Devices is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Neurovascular Devices market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.

Market Insights

Increasing Incidences of Neurovascular Diseases

Neurological diseases are the disorders of the brain, spine and the nerves that connect them and supplies oxygenated blood. The neurovascular systems is highly dependent on the continuous supply of oxygen and nutrients which is been supplied by the arteries and veins. The supply of oxygen and nutrients to the brain is essential for its working, therefore a defect in the system can impair the function and it may quickly become a life threatening factor. The neurovascular condition, diseases or disorders includes, ischemic stroke, hemorrhage stroke, brain aneurysm, vascular malformation, brain tumors and others. The lifestyle habits, genetic disorders, related chronic diseases may cause development of the neurovascular diseases. During recent years, the prevalence of neurological disorders have increased significantly. For instance, cerebral aneurysm is one of the neurovascular diseases that is rising significantly across the world. The prevalence of cerebral aneurysms has increased tremendously across the globe. Nearly, 30,000 people in the United States suffer from brain aneurysm rupture every year. A brain aneurysm ruptures every 18 minutes. The annual rate of rupture in the United States is found close to 8 to 10 per 100,000 people. Thus, it is estimated that the rising prevalence of cerebral aneurysms is likely to fuel the growth of the market during the forecast period.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Published Report - Neurovascular Devices Market: Strategic Insights

global-neurovascular-devices-report
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Neurovascular Devices Product -Based Insights

Based on product, the Neurovascular Devices market is segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, and support devices.

In 2019, the support devices segment accounted for the highest share of the market. Growth of this segment is attributed to the growing Increasing prevalence of neurological conditions such as stroke, brain aneurysm, arteriovenous malformations (AVMs), are few factors contributing toward the support devices market growth.

Type - Application

The global neurovascular devices market by application segments was led by ischemic strokes segment. In 2019, the ischemic strokes segment held a largest market share of the neurovascular devices market, by application. The ischemic strokes segment is expected to be the fastest growing segments of the market in 2027 owing to rise in the aging population. Increase in the incidences of cardiovascular diseases is expected to become the major factor for the growth of the neurovascular devices market

End User -Based Insights

Based on End User, the Neurovascular Devices market is segmented into Hospitals, Ambulatory Surgical Centers, and Specialized Clinics. The hospital segment held the largest share of the market in 2019 and is estimated to register the highest CAGR of 3.8% in the market during the forecast period.

Product launches and expansion strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide as well as to meet the growing demand.

The market players operating in the Neurovascular Devices market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

Neurovascular Devices

Published Report - Neurovascular Devices Market Report Scope

Report Attribute Details
Market size in 2019 US$ 3 Billion
Market Size by 2027 US$ 3.87 Billion
Global CAGR (2019 - 2027) 3.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Neurothrombectomy Devices
  • Aneurysm Coiling & Embolization Devices
  • Cerebral Balloon Angioplasty & Stenting Systems and Support Devices
By Application
  • Cerebral Aneurysms
  • Ischemic Strokes
  • Arteriovenous Malformation & Fistulas and Other Applications
By End User
  • Hospitals
  • Ambulatory Surgical Centers and Specialized Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson Services, Inc.
  • Acandis GmbH & Co. KG.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • phenox GMBH
  • Integer Holdings Corporation
  • Memry Corporation

Published Report - Neurovascular Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Neurovascular Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

global-neurovascular-devices-report-cagr

Global Neurovascular Devices Market – ByProduct

  • Neurothrombectomy Devices
    • Clot Retrieval Devices
    • Suction & Aspiration Devices
    • Snares
  • Aneurysm Coiling & Embolization Devices
    • Embolic Coils
      • Bare Detachable Coils
      • Coated Detachable Coils
    • Flow Diversion Devices
    • Liquid Embolic Agents
  • Cerebral Balloon Angioplasty & Stenting Systems
    • Carotid Artery Stents
    • Embolic Protection Systems
    • Balloon Occlusion Devices
    • Distal Fillers
  • Support Devices
    • Microcatheters
    • Microguidewies

By Global Neurovascular Devices Market – By Application

  • Cerebral Aneurysms
  • Ischemic Stroke
  • Arteriovenous Malformation & Fistulas
  • Other Applications

By Global Neurovascular Devices Market – By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America and Central America (SAM)
    • Brazil
    • Argentina

Company Profiles

  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson Services, Inc.
  • Acandis GmbH & Co. KG.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • phenox GMBH
  • Integer Holdings Corporation
  • Memry Corporation

Frequently Asked Questions

Neurovascular devices are used in neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.

The growth of the market is attributed to increasing incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, factor such as high cost of embolization coils and lack of expert professionals are the major restraining factors for the growth of the market.

These devices have important role in treatment of brain aneurysms and other vascular abnormalities. The devices are implanted in aneurysm sac for smooth blood flow by promoting thrombosis
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Jun 2024